Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

United States Antimony (UAMY) Other financing activities (2024 - 2025)

United States Antimony (UAMY) has disclosed Other financing activities for 2 consecutive years, with $11425.0 as the latest value for Q4 2025.

Quarterly Other financing activities changed N/A to $11425.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$331808.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$331808.0 for FY2025, 4247.6% down from the prior year.
Other financing activities hit $11425.0 in Q4 2025 for United States Antimony, up from -$409246.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $94922.0 in Q2 2024 to a low of -$409246.0 in Q3 2025.